DIABETIC NEPHROPATHY IN 2014 Improved cardiorenal prognosis in diabetic nephropathy

被引：10
|
作者：
Parving, Hans-Henrik [1 ]
Rossing, Peter [2 ]
机构：
[1] Univ Copenhagen, Rigshosp, Dept Med Endocrinol, DK-2100 Copenhagen, Denmark
[2] Steno Diabet Ctr, DK-2820 Gentofte, Denmark
来源：
NATURE REVIEWS NEPHROLOGY | 2015年 / 11卷 / 02期
关键词：
BARDOXOLONE METHYL; TYPE-2; ALBUMINURIA; MORTALITY;
D O I：
10.1038/nrneph.2014.238
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
In 2014, key studies in the field of diabetic nephropathy highlighted the importance of albuminuria as a predictor of cardiovascular risk and showed that the incidence of renal and cardiovascular complications is decreasing. Promising efficacy data were obtained with atrasentan, whereas a trial of bardoxolone methyl led to safety concerns.
引用
收藏
页码：68 / 69
页数：2
相关论文
共 50 条
  • [1] Improved prognosis of diabetic nephropathy in type 1 diabetes
    Andresdottir, Gudbjorg
    Jensen, Majken L.
    Carstensen, Bendix
    Parving, Hans-Henrik
    Hovind, Peter
    Hansen, Tine W.
    Rossing, Peter
    KIDNEY INTERNATIONAL, 2015, 87 (02) : 417 - 426
  • [2] A new classification of Diabetic Nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy
    Masakazu Haneda
    Kazunori Utsunomiya
    Daisuke Koya
    Tetsuya Babazono
    Tatsumi Moriya
    Hirofumi Makino
    Kenjiro Kimura
    Yoshiki Suzuki
    Takashi Wada
    Susumu Ogawa
    Masaaki Inaba
    Yoshihiko Kanno
    Takashi Shigematsu
    Ikuto Masakane
    Ken Tsuchiya
    Keiko Honda
    Kazuko Ichikawa
    Kenichiro Shide
    Clinical and Experimental Nephrology, 2015, 19 : 1 - 5
  • [3] A new classification of Diabetic Nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy
    Haneda M.
    Utsunomiya K.
    Koya D.
    Babazono T.
    Moriya T.
    Makino H.
    Kimura K.
    Suzuki Y.
    Wada T.
    Ogawa S.
    Inaba M.
    Kanno Y.
    Shigematsu T.
    Masakane I.
    Tsuchiya K.
    Honda K.
    Ichikawa K.
    Shide K.
    Diabetology International, 2014, 5 (4) : 207 - 211
  • [4] Diabetic nephropathy
    Menne, J.
    Haller, H.
    INTERNIST, 2011, 52 (05): : 495 - +
  • [5] A new classification of Diabetic Nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy
    Haneda, Masakazu
    Utsunomiya, Kazunori
    Koya, Daisuke
    Babazono, Tetsuya
    Moriya, Tatsumi
    Makino, Hirofumi
    Kimura, Kenjiro
    Suzuki, Yoshiki
    Wada, Takashi
    Ogawa, Susumu
    Inaba, Masaaki
    Kanno, Yoshihiko
    Shigematsu, Takashi
    Masakane, Ikuto
    Tsuchiya, Ken
    Honda, Keiko
    Ichikawa, Kazuko
    Shide, Kenichiro
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2015, 19 (01) : 1 - 5
  • [6] A new Classification of Diabetic Nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy
    Haneda, Masakazu
    Utsunomiya, Kazunori
    Koya, Daisuke
    Babazono, Tetsuya
    Moriya, Tatsumi
    Makino, Hirofumi
    Kimura, Kenjiro
    Suzuki, Yoshiki
    Wada, Takashi
    Ogawa, Susumu
    Inaba, Masaaki
    Kanno, Yoshihiko
    Shigematsu, Takashi
    Masakane, Ikuto
    Tsuchiya, Ken
    Honda, Keiko
    Ichikawa, Kazuko
    Shide, Kenichiro
    JOURNAL OF DIABETES INVESTIGATION, 2015, 6 (02) : 242 - 246
  • [7] Angiopoietins and diabetic nephropathy
    Gnudi, Luigi
    DIABETOLOGIA, 2016, 59 (08) : 1616 - 1620
  • [8] Diabetic Nephropathy
    Resl, Michael
    Clodi, Martin
    WIENER KLINISCHE WOCHENSCHRIFT, 2011, 123 : 67 - 77
  • [9] Diabetic nephropathy
    Wylie, Emma C.
    Satchell, Simon C.
    CLINICAL MEDICINE, 2012, 12 (05) : 480 - 482
  • [10] Diabetic nephropathy
    Sämann A.
    Wolf G.
    Der Nephrologe, 2013, 8 (4): : 355 - 366
12345